TOLMAR is a fully integrated pharmaceutical company focused on the development, approval, and commercialization of specialty pharmaceutical products, including a line of generic dermatology products, where TOLMAR is an established leader, and specialty injectable oncology products. Invention, development, and worldwide approval of ELIGARD® (leuprolide acetate for injectable suspension) for the palliative treatment of advanced prostate cancer has established TOLMAR as a leader dedicated to the urology community, providers, and patients. TOLMAR Pharmaceuticals is based in Lincolnshire, Illinois, with TOLMAR headquarters, product development, and manufacturing facilities based in Fort Collins, Colorado.
Our state-of-the-art facilities span over 300,000 square feet, housing chemistry and microbiology laboratories, multishift production operations, and cGMP-compliant manufacturing.
TOLMAR continuously seeks pharmaceutical licensing, acquisition, and partnership opportunities in specialty pharmaceutical areas. Contact us for more information.